One composite patient seen at 24 and again at 36, with the same diagnosis and opposite reproductive goals, gives the closing NU576 case study its two-part design. Searches like "nu 576 unit 10 assignment example", "nu576 unit 10 sample" and "nu576 unit 10 example" land here.
The Same Syndrome, Opposite Goals: A PCOS Case at 24 and at 36 Under the 2023 International Guideline
[Student Name]
Purdue University Global
NU576: NP II - Primary Care of Women's Health
Unit 10 Women's Health Case Study
[Instructor Name]
[Date]
The patient is a composite; values, doses and dates are bracketed.
Part 1: Age 24
Presentation. Ms. [N.], 24, a graphic designer, reports cycles every 45 to 90 days since her late teens and dark hair growing on her chin and upper lip over two years. Modified Ferriman-Gallwey score [12]. BMI [29]. Blood pressure [118/76]. No galactorrhea, no signs of Cushing syndrome, no rapid virilization. Tests. Total testosterone [raised]. TSH, prolactin and 17-hydroxyprogesterone normal, excluding thyroid disease, hyperprolactinemia and nonclassic congenital adrenal hyperplasia. Pregnancy test negative. Assessment. Polycystic ovary syndrome, by two of the three Rotterdam criteria, ovulatory dysfunction and hyperandrogenism, after other causes were excluded (Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, 2004). Once two criteria are met and other causes are excluded, the diagnosis is made, and a pelvic ultrasound adds nothing that would change it. The 2023 guideline notes that ultrasound is not required when irregular cycles and hyperandrogenism are both present (Teede et al., 2023). Plan.
1. Combined oral contraceptive with [30 mcg ethinyl estradiol], chosen to regulate cycles, protect the endometrium from unopposed estrogen, and reduce androgen-driven hair growth, as the guideline recommends for adults with PCOS not seeking pregnancy (Teede et al., 2023).
2. A 75 g oral glucose tolerance test, because women with PCOS are at increased risk of type 2 diabetes and the guideline prefers the glucose tolerance test for assessing glycemic status. Result: [normal].
3. Depression and anxiety screening, since both are more common in PCOS. Result: PHQ-9 [6].
4. Lifestyle support: activity and diet goals, framed around health rather than weight alone.
5. Hair: cosmetic options discussed; the pill's effect on hair growth takes about six months.
Why the pill, and not metformin or a progestin alone, at 24. She had two problems to treat, irregular cycles with the endometrial risk they carry and bothersome hair growth, and she did not want to conceive. A combined pill addresses all three at once: it regulates bleeding, protects the endometrium and lowers free testosterone by raising sex hormone-binding globulin. Metformin would have helped her glucose metabolism but done little for her hair or her need for contraception. A progestin alone would have protected the endometrium without helping the hirsutism. The choice was made for her goals at that visit, and it was the right one for them.
What she was told at 24. PCOS is common, it is not her fault, and it is a long-term condition that affects more than periods: weight, glucose, mood and, later, fertility. The pill treats the symptoms but does not cure the syndrome, and her fertility will need attention when she wants a pregnancy. That last sentence mattered twelve years later, because she came back remembering it.
Bridge: Twelve Years in Five Lines
1. Continued the combined pill; cycles regular, hirsutism improved.
2. BMI rose from 29 to [32].
3. Oral glucose tolerance tests every [one to three] years: normal until [34], then impaired glucose tolerance.
4. Mood stable; one episode of depression at [30], treated with therapy.
5. Married at [33]; now wants to conceive.
Part 2: Age 36
Presentation. Ms. [N.], 36, stopped the pill [four] months ago to conceive. Cycles have returned to every 50 to 80 days. BMI 32. Blood pressure [124/80]. Tests. Pregnancy test negative. Oral glucose tolerance test: [impaired glucose tolerance], as at 34. TSH normal. Assessment. PCOS with anovulatory infertility, impaired glucose tolerance and age 36. Plan.
1. Preconception care: [folic acid], a prenatal vitamin, rubella and varicella immunity checked, blood pressure and glucose optimized.
2. Glycemic status: impaired glucose tolerance raises the risk of gestational diabetes; lifestyle measures and a discussion of [metformin] with the fertility team.
3. Weight: a modest loss, even 5 percent, can restore ovulation in some women with PCOS; offered with support, without delaying referral.
4. Ovulation induction: referral to reproductive endocrinology now. The guideline recommends letrozole as the first-line drug for ovulation induction in PCOS (Teede et al., 2023). In a large randomized trial, letrozole produced more live births than clomiphene in women with PCOS (Legro et al., 2014).
5. Referral timing: with irregular cycles, she is not expected to conceive without help, and at 36 fertility declines further with each year, so she is referred now rather than after a year of trying.
What she was told at 36. Stopping the pill did not cause her irregular cycles; it uncovered the pattern the pill had been masking. She is likely to need help to ovulate, and letrozole, taken for five days early in a cycle, is the first step most fertility teams use. Her impaired glucose tolerance means pregnancy will bring closer glucose monitoring, and improving it now lowers her risk of gestational diabetes. Her age is a reason to start now rather than wait a year, not a reason for alarm.
What would change the plan. Signs of a condition other than PCOS, such as a very high testosterone or rapid virilization, would prompt a search for an androgen-secreting tumor. An abnormal semen analysis in her partner, part of the fertility evaluation, would change the treatment path. And if her glucose tolerance progresses to diabetes, preconception care would add tighter glucose control before any attempt to conceive.
Synthesis: Three Decisions From 24 That Still Matter at 36
1. The glucose tolerance test. Starting it at 24 and repeating it built the record that showed impaired glucose tolerance at 34, which now shapes preconception care.
2. The combined pill. It regulated her cycles and protected her endometrium for twelve years; stopping it now reveals the anovulation it was treating, which is why ovulation induction is needed.
3. Depression screening. Her history of depression is known, so the stress of fertility treatment can be anticipated and support offered early.
What the Two Visits Show
The same syndrome was managed toward opposite goals: suppressing ovulation at 24 and inducing it at 36. The guideline governs both, but the plan at each visit was set by what she wanted at the time. The headings stayed the same; what went under them changed because her goal did. The continuity between the two visits came from the record: the glucose results, the mood history and the sentence about fertility she remembered. A clinician meeting her for the first time at 36 would have had to rebuild all three, and the case is an argument for keeping them where the next clinician can find them.
References
Legro, R. S., Brzyski, R. G., Diamond, M. P., Coutifaris, C., Schlaff, W. D., Casson, P., Christman, G. M., Huang, H., Yan, Q., Alvero, R., Haisenleder, D. J., Barnhart, K. T., Bates, G. W., Usadi, R., Lucidi, S., Baker, V., Trussell, J., Krawetz, S. A., Snyder, P., ... Zhang, H. (2014). Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. New England Journal of Medicine, 371(2), 119-129. https://doi.org/10.1056/NEJMoa1313517
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. (2004). Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility, 81(1), 19-25. https://doi.org/10.1016/j.fertnstert.2003.10.004
Teede, H. J., Tay, C. T., Laven, J. J. E., Dokras, A., Moran, L. J., Piltonen, T. T., Costello, M. F., Boivin, J., Redman, L. M., Boyle, J. A., Norman, R. J., Mousa, A., & Joham, A. E. (2023). Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Journal of Clinical Endocrinology & Metabolism, 108(10), 2447-2469. https://doi.org/10.1210/clinem/dgad463
How this NU576 Unit 10 example is structured
The two parts mirror each other so a reader can compare them heading by heading: presentation, assessment, plan, and the evidence behind it. That parallel form carries the course's central idea, since identical headings hold different content once her goals reverse. Part one shows the diagnostic reasoning in full, including why an ultrasound was not needed once two criteria were met, and treats the pill as management of cycles and hair growth, not as contraception alone. The bridge records what persisted across twelve years: weight, glucose results, mood. Part two opens with what changes when pregnancy is the goal, discontinuing the pill and adding preconception care, and explains the referral timing given her age and irregular cycles. A closing synthesis names three decisions from the first visit that still matter at the second.
Get an NU576 Unit 10 example written to your instructions
Closing NU576 cases vary in patient and in which two life stages they span, so the full case text is needed, rubric included. The study that returns keeps parallel headings across both visits, brackets every agent and dose, and ends with a synthesis tying the stages together. Allow 24-48h; a first study is free. The paper above is an original model document written by our desk, not a submitted student paper and not an official Purdue University Global document.
NU576 Unit 10 questions, answered
Can the two life stages be written as separate papers joined together?
Structurally they can look separate, but the grade usually depends on the connection. A short bridge and a synthesis naming decisions from the first visit that matter at the second make the case one argument. Without them, a grader may read two short papers and score neither as a case study.
Which PCOS guidance should the paper cite?
The 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome is the current standard and is widely cited. It updated diagnostic criteria, including an option to use anti-Mullerian hormone in adults, and named first-line treatments for infertility. Cite it with its year and apply its recommendations explicitly.
How long should a two-stage case study be?
Follow your rubric, but six to eight pages is common, split roughly evenly between the two stages with a page for the bridge and synthesis. If space is short, trim background history before trimming the reasoning, since the assessment and plan sections carry most of the marks in both parts.